Pharmathen Overview

Life ScienceCompany

Is Pharmathen PE-backed?

Yes. Pharmathen is owned by private equity investors CVC Capital Partners and Partners Group.

Was Pharmathen formerly PE-backed?

Yes. Pharmathen was formerly owned by 1 private investor.

Where is Pharmathen headquartered?

Pharmathen is headquartered in Amstelveen, Netherlands.

How many employees does Pharmathen have?

Pharmathen has 1,000 employees.

What sector is Pharmathen in?

Pharmathen is a life science company.

When was Pharmathen founded?

Pharmathen was founded in 1969.

Pharmathen

Pharmathen Global BV

9, Van Heuven Goedhartlaan,
Amstelveen, 1181 LE
Netherlands,
+31 (0) 20 799 5085
www.pharmathen.com

Pharmathen is a European pharmaceutical company that focuses on developing, manufacturing, and out-licensing complex generic pharmaceutical products. Pharmathen's differentiated B2B model attracts a blue-chip customer base of more than 215 generic pharmaceutical companies, which it serves from two US/EU-approved manufacturing facilities in Greece. Pharmathen was founded in 1969 and is based in Amstelveen, Netherlands.



Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Pharmathen

Life Science Companies , Netherlands Companies